Vaalavirta L - Search Results

1

VMAT technique enables concomitant radiotherapy of prostate cancer and pelvic bone metastases.

Kiljunen T, Kangasmäki A, Aaltonen A, Kairemo K, Partanen K, Joensuu G, Alanko T, Vaalavirta L, Joensuu T. Kiljunen T, et al. Among authors: vaalavirta l. Acta Oncol. 2015 Jun;54(6):847-53. doi: 10.3109/0284186X.2014.962665. Epub 2014 Oct 13. Acta Oncol. 2015. PMID: 25307406

2

Patterns of relapse following surgery and postoperative intensity modulated radiotherapy for oral and oropharyngeal cancer.

Collan J, Lundberg M, Vaalavirta L, Bäck L, Kajanti M, Mäkitie A, Tenhunen M, Saarilahti K. Collan J, et al. Among authors: vaalavirta l. Acta Oncol. 2011 Oct;50(7):1119-25. doi: 10.3109/0284186X.2010.549839. Epub 2011 Jan 19. Acta Oncol. 2011. PMID: 21247264

3

Inter-observer variation in target delineation and dose trade-off for radiotherapy of paediatric ependymoma.

Toussaint L, Brandal P, Embring A, Engellau J, Evensen ME, Griskeviskius R, Hansen J, Hietala H, Wickart Johansson G, Jørgensen M, Kramer PH, Kristensen I, Lehtio K, Magelssen H, Maraldo MV, Marienhagen K, Martinsson U, Nilsson K, Peters S, Plaude S, Seiersen K, Sendiuliene D, Smulders B, Edvardsen T, Søbstad JM, Taheri Z, Vaalavirta L, Vestergaard A, Timmermann B, Lassen-Ramshad Y; NOPHO Radiotherapy Working Group. Toussaint L, et al. Among authors: vaalavirta l. Acta Oncol. 2022 Feb;61(2):235-238. doi: 10.1080/0284186X.2021.2022202. Epub 2021 Dec 31. Acta Oncol. 2022. PMID: 34970940 No abstract available.

4

Chemoradiotherapy of anal cancer is feasible in elderly patients: treatment results of mitomycin-5-FU combined with radiotherapy at Helsinki University Central Hospital 1992-2003.

Saarilahti K, Arponen P, Vaalavirta L, Tenhunen M, Blomqvist C. Saarilahti K, et al. Among authors: vaalavirta l. Acta Oncol. 2006;45(6):736-42. doi: 10.1080/02841860600849075. Acta Oncol. 2006. PMID: 16938817

5

Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up.

Ahtiainen V, Vaalavirta L, Tenhunen M, Joensuu H, Mäenpää H. Ahtiainen V, et al. Among authors: vaalavirta l. Acta Oncol. 2020 Sep;59(9):1064-1071. doi: 10.1080/0284186X.2020.1785003. Epub 2020 Jun 30. Acta Oncol. 2020. PMID: 32603613 Clinical Trial.

6

Patterns of relapse following definitive treatment of head and neck squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin.

Loimu V, Collan J, Vaalavirta L, Bäck L, Kapanen M, Mäkitie A, Tenhunen M, Saarilahti K. Loimu V, et al. Among authors: vaalavirta l. Radiother Oncol. 2011 Jan;98(1):34-7. doi: 10.1016/j.radonc.2010.10.015. Epub 2010 Nov 11. Radiother Oncol. 2011. PMID: 21074875

7

Increased pancreatic cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Børge Johannesen T, Gilbert ES, Stovall M, van Leeuwen FE, Rajaraman P, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF Jr, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Morton LM, Fossa SD, Travis LB. Hauptmann M, et al. Among authors: vaalavirta l. Br J Cancer. 2016 Sep 27;115(7):901-8. doi: 10.1038/bjc.2016.272. Epub 2016 Sep 6. Br J Cancer. 2016. PMID: 27599043 Free PMC article.

8

The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer.

Saarilahti K, Arponen P, Vaalavirta L, Tenhunen M. Saarilahti K, et al. Among authors: vaalavirta l. Radiother Oncol. 2008 Jun;87(3):383-90. doi: 10.1016/j.radonc.2008.04.011. Epub 2008 May 22. Radiother Oncol. 2008. PMID: 18501454

9

TEDDI: radiotherapy delivery in deep inspiration for pediatric patients - a NOPHO feasibility study.

Lundgaard AY, Hjalgrim LL, Rechner LA, Josipovic M, Joergensen M, Aznar MC, Berthelsen AK, Borgwardt L, Johansen C, Loft A, Safwat A, Vaalavirta L, Specht L, Maraldo MV. Lundgaard AY, et al. Among authors: vaalavirta l. Radiat Oncol. 2018 Mar 27;13(1):56. doi: 10.1186/s13014-018-1003-4. Radiat Oncol. 2018. PMID: 29587881 Free PMC article. Clinical Trial.

10

Primary pericardial mesothelioma: a case report of a patient treated with an immune checkpoint inhibitor as the second-line treatment.

Arponen O, Salo V, Lönnberg A, Vaalavirta L, Koivu H, Nyandoto P. Arponen O, et al. Among authors: vaalavirta l. Acta Oncol. 2021 May;60(5):687-691. doi: 10.1080/0284186X.2021.1887515. Epub 2021 Feb 23. Acta Oncol. 2021. PMID: 33620252 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page